Madeline Gregory
Sickle-cell disease targeted by CRISPR in potential first human application
The breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by Jennifer Doudna, a UC Berkeley professor of biochemistry and molecular biology, may soon be ...